View of 978 – The impact of axillary lymph node dissection on the indication of adjuvant abemaciclib in highrisk hormone receptor-positive breast cancer: realworld analysis from a multicenter cohort in Brazil

Return to Article Details 978 – The impact of axillary lymph node dissection on the indication of adjuvant abemaciclib in highrisk hormone receptor-positive breast cancer: realworld analysis from a multicenter cohort in Brazil Download Download PDF